Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404985 · ClinicalTrials.gov registry record · NA
Endovascular vs Surgical Arteriovenous Fistula Outcomes
A NA study of Dialysis Fistula Creation and Endo-vascular AVFs, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04404985: Active NA study of Dialysis Fistula Creation and Endo-vascular AVFs, sponsored by University of Alabama at Birmingham.
NCT04404985 is a NA study of Dialysis Fistula Creation and Endo-vascular AVFs that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404985, a NA study of Dialysis Fistula Creation and Endo-vascular AVFs, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. There are two techniques of creating AVFs either the traditional way with surgery( Surgical AVFs) or novel per-cutaneous technique Endo- AVFs. Investigators will pilot an randomized clinical trial of endo-AVFs and surgical AVFs at University of Alabama at Birmingham to determine the feasibility of patient recruitment, randomization, and retention. This pilot study will set the stage for a full-scale randomized clinical trial in future.
Primary Outcome
Assess by ultrasound . To assess blood flow within the fistula.
Conditions Studied
Interventions
- PROCEDURE Surgical AVF
- PROCEDURE Endo-vascular AVF
Study Locations (1)
Alabama
- UAB - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT04404985 still lists
NCT04404985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Dialysis Fistula Creation appearing as the primary indexed condition, and to 2 interventions - of which Surgical AVF is the first listed.
NCT04404985 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04404985 about?
NCT04404985 is a clinical study titled "Endovascular vs Surgical Arteriovenous Fistula Outcomes". Arteriovenous fistulas (AVFs) are the preferred type of vascular access for dialysis, but many of them fail to mature. There are two techniques of creating AVFs either the traditional way with surgery( Surgical AVFs) or novel per-cutaneous technique Endo- AVFs. Investigators will pilot an randomize...
What is the current status of trial NCT04404985?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2022-05-01. Estimated completion is 2026-06-30.
What conditions does trial NCT04404985 study?
This clinical trial studies the following conditions: Dialysis Fistula Creation, Endo-vascular AVFs.
What interventions are being tested in trial NCT04404985?
The interventions under investigation include: Surgical AVF (PROCEDURE), Endo-vascular AVF (PROCEDURE).
Who is sponsoring clinical trial NCT04404985?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04404985 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04404985's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI